Supplementary Table 2 from Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

Authors :: Eric Angevin
Michael Shi
Matthew Squires
Nicoletta Pirotta
Sarah Beall
Andrea Harzstark
Jürgen E. Gschwend
Chia-Chi Lin
Daniel Castellano
Yen-Chuan Ou
Alain Ravaud
Viktor Grünwald
Bernard Escudier
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 25KB, Supplemental Table 2 contains a summary of the newly occurring qualitative ECG abnormalities.

Full Text Access

Tools